Thomas Story & Son LLC Abbott Laboratories Transaction History
Thomas Story & Son LLC
- $239 Million
- Q4 2024
A detailed history of Thomas Story & Son LLC transactions in Abbott Laboratories stock. As of the latest transaction made, Thomas Story & Son LLC holds 65,589 shares of ABT stock, worth $9.05 Million. This represents 3.11% of its overall portfolio holdings.
Number of Shares
65,589
Previous 66,544
1.44%
Holding current value
$9.05 Million
Previous $7.59 Million
2.21%
% of portfolio
3.11%
Previous 3.09%
Shares
20 transactions
Others Institutions Holding ABT
# of Institutions
3,371Shares Held
1.36BCall Options Held
10.6MPut Options Held
8.73M-
Vanguard Group Inc Valley Forge, PA169MShares$23.3 Billion0.34% of portfolio
-
Black Rock Inc. New York, NY131MShares$18.1 Billion0.31% of portfolio
-
State Street Corp Boston, MA77.2MShares$10.6 Billion0.35% of portfolio
-
Capital International Investors Los Angeles, CA68MShares$9.38 Billion1.51% of portfolio
-
Capital Research Global Investors Los Angeles, CA54.1MShares$7.47 Billion1.31% of portfolio
About ABBOTT LABORATORIES
- Ticker ABT
- Exchange NYSE
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 1,751,219,968
- Market Cap $242B
- Description
- Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...